Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The collagen-hyaluronan network represents a complex structural association between type I collagen fibrils and hyaluronan polymers within the extracellular matrix. Collagen provides tensile strength and forms hierarchical fibrillar networks, while hyaluronan contributes hydration, viscoelasticity, and space-filling functions. Hyaluronan interacts with the collagen meshwork largely through its hydrophilic properties, occupying interfibrillar spaces, contributing to matrix swelling pressure, and affecting compressive stiffness of tissues. This network is essential for regulating cellular behaviors such as migration, adhesion, and proliferation and plays a critical role in normal tissue integrity, wound healing, and pathological processes including fibrosis, chronic inflammation, and tumor invasion. It is a biomaterial context or matrix environment rather than a discrete, targetable molecular entity.
Not applicable as a unified target; but enzymatic degradation (collagenase, hyaluronidase) modifies matrix structure and tissue architecture. In tissue engineering, chemical crosslinking alters network stability, mechanical strength, and cell response.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen-hyaluronan network.